, Tracking Stock Market Picks
Enter Symbol:
Becton, Dickinson And Company (BDX) [hlAlert]

down 45.37 %

Becton, Dickinson And Company (BDX) rated Underperform by BofA/Merrill

Posted on: Monday,  Dec 17, 2012  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Underperform Becton, Dickinson And Company (NYSE: BDX) on 12/17/2012, when the stock price was $78.08. Since
then, Becton, Dickinson And Company has gained 83.08% as of 01/27/2016's recent price of $142.95.
If you would have followed this BofA/Merrill's recommendation on BDX, you would have lost 45.37% of your investment in 1136 days.

Becton, Dickinson and Co. is engaged principally in the manufacture and sale of a broad line of supplies, devices and systems used by health care professionals, medical research institutions and the general public. BD's operations consist of three worldwide business segments: Medical Systems, Biosciences, and Preanalytical Solutions.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/17/2012 8:25 AM Sell
as of 12/31/2012
1 Week up  0.47 %
1 Month down  -0.14 %
3 Months   
1 YTD down  -0.14 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy